Head-to-head · Value Score
Alan Meds vs Ageless
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Ageless a 83. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#5 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameAgeless
#25 · Grade B+ · Good Value
Est. first month
$119/mo
Save ~91% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 83 — an est. $99/mo first month, with no teaser step-up baked in. Ageless isn't out of it: Bargain shoppers who want a low compounded sticker on both molecules (injectable or oral) and will do their own diligence on a newer, broad storefront.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | Ageless |
|---|---|---|
| Value Score | 90 (A) | 83 (B+) |
| Est. first month | $99/mo | $119/mo |
| Save vs brand-name | ~93% | ~91% |
| Semaglutide | $99/mo | $119/mo |
| Tirzepatide | $145/mo | $169/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Varies by state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
Ageless
Some of the lowest published compounded GLP-1 stickers we track ($119 sema / $169 tirz), inside a very broad compounded storefront — real savings, but on a thin, compounded-only track record.
Why it's a deal
- Among the lowest published compounded GLP-1 prices we track — $119 semaglutide, $169 tirzepatide
- Both molecules in injectable and oral/troche formats, no insurance, financing available
- Broad one-roof compounded menu (GLP-1 plus NAD+, sermorelin, LDN) with upfront not-FDA-approved disclaimers
The fine print
- Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
- Oral GLP-1 drops/troches lack the absorption and efficacy evidence of injectables
- No published state list and no named legal entity; advertised prices are floors before clinical review
- Thin public track record and few independent reviews for a very broad storefront
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.